Arbitrator issued interim award and Injunction to prevent future wrongdoing by Prime Therapeutics in antitrust case brought by AIDS Healthcare Foundation Regarding AHF's arbitration victory over ...

A safety net health care provider has won a $10.3 million interim arbitration judgment against Eagan-based Prime Therapeutics over price-fixing allegations between the local pharmacy benefits ...

It said that in addition to the monetary award, Widman issued an injunction against Prime Therapeutics, enjoining the pharmacy benefit manager from engaging in price-fixing discussions with ...

and Paperplane Therapeutics is a prime example. Our government is proud to support the development of solutions that improve both the quality and accessibility of patient care.” “Paperplane ...

Augustine Therapeutics appoints Gerhard Koenigas Chief Executive Officer as Company Prepares to Enter the ClinicIndustry veteran Gerhard Koenig, ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Learn more about whether Halozyme Therapeutics, Inc. or TG Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether PTC Therapeutics, Inc. or Vericel Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A newly published review in Genes & Diseases explores the oncogenic activation of PIK3CA in cancer and highlights emerging ...

BOSTON--(BUSINESS WIRE)--Atalanta Therapeutics, a biotechnology company ... and GHR Foundation alongside existing investor F-Prime Capital. “This financing validates the truly transformative ...

Atalanta Therapeutics has bagged $97 million ... Existing investor F-Prime Capital also joined the round, with participation from new investors Novartis Venture Fund, RiverVest Venture Partners ...